No Data
No Data
Insider decrases its stake in Prism Biolab(206A.JP) to 10.12%
On Oct 18, DCIパートナーズ株式会社 submitted the Change Report to Ministry of Finance. The report shows that DCIパートナーズ株式会社 decreased their holdings in $Prism Biolab(206A.JP)$, with their joint
Insider decrases its stake in Prism Biolab(206A.JP) to 7.32%
On Oct 18, ライフサイエンスベンチャーキャピタル株式会社 submitted the Change Report to Ministry of Finance. The report shows that ライフサイエンスベンチャーキャピタル株式会社 decreased their holdings in $Prism Biolab(206A.JP)$, with their
Insider decrases its stake in Prism Biolab(206A.JP) to 11.17%
On Oct 8, DCIパートナーズ株式会社 submitted the Change Report to Ministry of Finance. The report shows that DCIパートナーズ株式会社 decreased their holdings in $Prism Biolab(206A.JP)$, with their joint shareholding
Stocks that moved the previous day part1 Senko HD, Gelbins, Gelbins, etc.
Stock Name <Code> 2nd day closing price ⇒ change from previous day * Daiseki<9793> 3645 -115. Operating profit for the previous period decreased by 5.4% and the first quarter decreased by 0.7%, leading to an expanded decline in profit. * Claudia<3607> 353 -2924 The financial results for the fiscal year ending August 2024 showed a significant underperformance, resulting in a reversal of declining profits. * PRISMBio<206A> 415 -39 Reports of extending the hand of partnership with Eisai and others led to a sharp rise in the previous day. Profit-taking sales are dominant today. * Senco HD<9069> 1276 +31 Favorable profit-taking sales today due to the effect of a tariff revision.
Emerging markets stock digest: Jelbins significantly extended, Rainfall Sunlight hit the daily limit
<150A> JSH 621 -1 deadlock. It has been announced that a new branch of the home medical care business, 'Visiting Nurse Station Cordiale Edogawa Sales Office,' has been established in Edogawa-ku, Tokyo. 'Visiting Nurse Station Cordiale' is a psychiatric home visit medical support service office. The number of psychiatric patients is increasing year by year, and the demand for home medical care that can be received at home is expanding, so efforts are being made to expand the area. <206A> PRISMBio 415 -39
PRISM Bio fell sharply, profit-taking sell-off after the previous day's sharp rise, reported to be reaching out for partnerships with Eisai etc.
Marked decrease. Profit-taking sell-off is occurring in reaction to the sharp rise the previous day. Some media reported that there has been a rush of buying due to the evaluation of technology that efficiently synthesizes compounds that target proteins related to the cause and treatment effects of diseases, not only by major domestic companies like Eisai <4523>, but also by mega-pharmas extending their partnership. However, today it seems that selling is leading as it was pushed back near the 25-day moving average line.
No Data
No Data